Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) shares dropped 8.2% during trading on Thursday . The company traded as low as $7.10 and last traded at $8.00. Approximately 11,869 shares were traded during trading, a decline of 32% from the average daily volume of 17,517 shares. The stock had previously closed at $8.71.
Fortress Biotech Stock Performance
The business’s 50 day simple moving average is $7.00 and its 200 day simple moving average is $6.63.
About Fortress Biotech
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Recommended Stories
- Five stocks we like better than Fortress Biotech
- What is the MACD Indicator and How to Use it in Your Trading
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- NYSE Stocks Give Investors a Variety of Quality Options
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- What Are Dividend Challengers?
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
